Roche RHHBY announced that the FDA has approved pipeline candidate, inavolisib, for the treatment of breast cancer, under the ...

Roche Holding AG will add manufacturing capacity in China to serve the country’s growing market, making it the latest ...

Jazz Pharmaceuticals’ Zepzelca, once on the brink of a market withdrawal, has returned with new trial results showing it ...

As Roche comes under competitive pressure on its breast cancer business, the Swiss company hopes a new drug will add a ...

With the regulatory approval for advanced breast cancer, Roche’s inavolisib is a potential challenger to Novartis’ PI3K ...

J.P. Morgan analyst Richard Vosser maintained a Sell rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of ...

Roche's experimental oral drug for breast cancer giredestrant could enter a market worth at least 10 billion Swiss francs ...

Some trails in the park in central Wisconsin reopened Friday to hikers days after a fire damaged stairway that leads to the ...

Novartis' Piqray/Vijoice (alpelisib) is the only PIK3CA inhibitor to have reached the market for breast cancer, having been ...

Footballer Stephanie Roche has admitted it was “an emotional day” when she hung up her football boots for the final time. On ...

Skin care aficionados everywhere are making space for a dermatologist-backed, budget-friendly brand in their medicine ...

We’ve rounded up the best, expert-recommended products to treat hyperpigmentation in dark skin, including cleansers, serums, ...